Shigetarou Mori

Shigetarou Mori

Auto-generated profile, based on publicly available information

Shigetarou Mori

Department of Bacteriology II, National Institute of Infectious Diseases, Musashi-Murayama, Tokyo, 208-0011, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DVDavid Vizarraga
David Vizarraga
AKAkihiro Kawamoto
Akihiro Kawamoto
UMU. Matsumoto
U. Matsumoto
RIRamiro Illanes
Ramiro Illanes
RPRosa Pérez-Luque
Rosa Pérez-Luque
DADavid Aparicio
David Aparicio
Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.

1 July 2016 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JWJun-Ichi Wachino
Jun-Ichi Wachino
YYYoshihiro Yamaguchi
Yoshihiro Yamaguchi
SMShigetarou Mori
Shigetarou Mori
WJWanchun Jin
Wanchun Jin
KKKouji Kimura
Kouji Kimura
YAYoshichika Arakawa
Yoshichika Arakawa
Metallo-β-lactamases (MBLs) confer resistance to carbapenems, and their increasing global prevalence is a growing clinical concern. To elucidate the mechanisms by which these enzymes recognize and hydrolyze carbapenems, we solved 1.4 to 1.6 Å crystal structures of SMB-1 ( S erratia m etallo- β -lactamase 1), a subclass B3 MBL, bound to hydrolyzed carbapenems (doripenem, meropenem, and imipenem). In these structures, SMB-1 interacts mainly with the carbapenem core structure via elements in the active site, including a zinc ion (Zn-2), Q157[113] (where the position in the SMB-1 sequence is in brackets after the BBL number), S221[175], and T223[177]. There is less contact with the carbapenem R2 side chains, strongly indicating that SMB-1 primarily recognizes the carbapenem core structure. This is the first report describing how a subclass B3 MBL recognizes carbapenems. We also solved the crystal structure of SMB-1 in complex with the approved drugs captopril, an inhibitor of the angiotensin-converting enzyme, and 2-mercaptoethanesulfonate, a chemoprotectant. These drugs are inhibitors of SMB-1 with K i values of 8.9 and 184 μM, respectively. Like carbapenems, these inhibitors interact with Q157[113] and T223[177] and their thiol groups coordinate the zinc ions in the active site. Taken together, the data indicate that Q157[113], S221[175], T223[177], and the two zinc ions in the active site are key targets in the design of SMB-1 inhibitors with enhanced affinity. The structural data provide a solid foundation for the development of effective inhibitors that would overcome the carbapenem resistance of MBL-producing multidrug-resistant microbes.

21 May 2004 in Journal of Basic Microbiology
Verified
Journal Article
Closed access
PDF file
SKShigeyuki Kawai
Shigeyuki Kawai
SMShigetarou Mori
Shigetarou Mori
TMTakako Mukai
Takako Mukai
KMKousaku Murata
Kousaku Murata

4 April 2024 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
NMNami Miura-Ajima
Nami Miura-Ajima
PSPondpan Suwanthada
Pondpan Suwanthada
SKSiriporn Kongsoi
Siriporn Kongsoi
HKHyun Kim
Hyun Kim
RPRuttana Pachanon
Ruttana Pachanon
Yasuhiko SuzukiYasuhiko Suzuki
Yasuhiko Suzuki

9 November 2026 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YSYushi Shinozaki
Yushi Shinozaki
RHRyota Hase
Ryota Hase
SISaya Ikegami
Saya Ikegami
MYMana Yamashiro
Mana Yamashiro
KHKimihito Hirose
Kimihito Hirose
DSDaiki Saito
Daiki Saito